Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodi Supply Disruption — Cardinal Health Inc. (Moderat
Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodi Supply Disruption — Cardinal Health Inc. (Moderat is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodi; Manufacturer: Cardi
| Drug name | Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodi |
|---|---|
| Manufacturer | Cardinal Health Inc. |
| Recall/Disruption reason | CGMP Deviations: Intermittent exposure to temperature excursion during storage. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0403-2021 |
| Initiation date | 20210315 |
| Quantity affected | 210 cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →